PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Paul doesn't sound completely confident that a deal would...

  1. 850 Posts.
    lightbulb Created with Sketch. 210
    Paul doesn't sound completely confident that a deal would provide enough capital (50-60m USD) to cover the phase 3 costs. It baffles me that we could be giving up 85% of the asset's revenue in the US for example, for anything less than a number in the 100s of millions.
    Last edited by Duke2: 26/07/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.